This study is aimed at studying NAFLD bile acid metabolism changes and FXR signaling pathway, exploring the effect of probiotics on the pathway, and seeking new therapy for NAFLD to provide a theoretical and experimental basis. Here, NR1H4 is linked to metabolic dysfunction-associated steatotic liver disease.